Bekiroglu Elizabeth
- SEC CIK
- 0001884087
No open-market purchases or sales filed in the past year.
Current role at each company
- JBIO Jade Biosciences, Inc.See Remarksas of Feb 13, 2026
- ICVX Icosavax, Inc.General Counsel & Corp. Sec.as of Feb 17, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bekiroglu Elizabeth as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ICVX Icosavax, Inc.
General Counsel & Corp. Sec.2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2023 (view filing) | Feb 13 | 2 days | Bekiroglu ElizabethGeneral Counsel & Corp. Sec. | SSale | −5.92K | $10.69 | −$63.3K | −5.4%103.0K after | |
| Sep 9, 2022 (view filing) | Sep 8 | 1 day | Bekiroglu ElizabethGeneral Counsel & Corp. Sec. | SSale | −1.81K | $4.87 | −$8.83K | −1.6%108.9K after |